Novelna, a biotech company in the United States, announced a revolutionary protein-based test that shows promise as a less intrusive and more effective way to screen for 18 different types of cancer in their early stages. The researchers believe their discovery has the potential to be a medical Read More...
A new method of detecting early-stage cancer is getting the green light from the FDA, meaning human trials will commence in the coming two years. The new imaging method was intended for detecting metastatic cancer in the liver, but the researchers say it could be applied to a number of other types Read More...